Please login to the form below
cost
This page shows the latest cost news and features for those working in and with pharma, biotech and healthcare.
Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate
Judgement arrives ahead of European approval. GW Pharma’s Epidyolex for two types of severe treatment-resistant epilepsy has been given a preliminary rejection by England’s NICE – but the cost ... In the US, the oral liquid product costs $32, 500
Latest news
-
NICE’s long-serving chief exec Sir Andrew Dillon to step down
Pharma leader praises "laser focus" on thorny access questions. Sir Andrew Dillon has announced that he will step down as chief executive of England’s cost-effectiveness watchdog NICE at the ... NICE isn’t free of controversy, however, and there
-
NICE’s fast-track catapults Skyrizi into market
In 2017/18, Humira was by far the biggest drug cost for the NHS in England, at £495m, but will record steep decline this financial year. ... NICE says in cost terms, it is ‘appropriate’ to compare Skyrizi with Tremfya, and says the total costs
-
Roche’s Hemlibra scores broader NHS funding
NHS England will have undoubtedly driven a hard bargain during confidential talks on the drug's price in exchange for market access, though it releases scant details about its cost effectiveness
-
AstraZeneca buys FDA priority review voucher from Sobi
The FDA’s PRV is used as an incentive for companies to invest in orphan drugs, by promising a cost reduction for the application fee for future products and a
-
Novartis chooses internal replacement for US pharma president role
However, the response to Novartis’ handling of the data manipulation has faced harsh criticism from notable figures, including US cost-effectiveness watchdog ICER and a group of prominent US senators.
More from news
Approximately 9 fully matching, plus 2,753 partially matching documents found.
Latest Intelligence
-
AI is transforming pharma R&D – now it can transform pharma marketing
The benefits are clear: faster drug discovery, while reducing the cost, time and risk of getting new medicines to market. ... Chatbots present a low risk, low cost way for pharma marketing pacesetters to.
-
Real-world studies
One of the most impactful places that RWD can be used to cut time and costs is in enrolment processes which can consume up to 40% of the clinical trial budget.
-
A new era in European Parliament: policymakers need to hear from pharma
Green parties, for example, tend to be critical of the cost of medicines, while others on the right have disparaged the safety and efficacy of childhood vaccinations.
-
The fight for affordable insulin
The company commented: “We are focused on bringing down the cost people pay at the pharmacy. ... Another initiative is a cross-border run into Canada by groups of type 1 patients, where insulin can be purchased at a tenth of the cost.
-
Re-imagining content supply chains for a next-gen customer experience in pharma
In terms of maximising utility of content supply chain, we are focusing on five KPIs: use of content, re-use of content, cost of content, quality of content and time to ... These KPIs are driven from two needs. First, the need for efficiency, we simply
More from intelligence
Approximately 2 fully matching, plus 443 partially matching documents found.
Latest appointments
-
Merck appoints new chief information officer
He has a proven track record in successfully managing large-scale IT transformation initiatives, as well as building cost-effective international IT organisations.”.
-
Peter Kelly named managing director of Accord Healthcare UK
We remain committed to R&D and bringing cost competitive new products to market at the earliest opportunity.
-
IFPMA appoints Fumie Griego as assistant director general
and background in global affairs, including intellectual property protection, pricing, costs, value issues and health diplomacy.
-
Sandoz UK promotes Tim de Gavre to country head
As a market, the UK has one of the highest levels of generic use of any global market, and the NHS is also under severe cost pressures. ... Our combined portfolio of small molecule generics and biosimilars makes a significant different to medicines costs,
-
EY appoints global life sciences industry leader
New solutions will be required to meet the global challenges of sustainability of healthcare systems, aging populations, chronic disease and increasing cost pressures.
More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.
Latest from PMHub
-
Valid Insight: TRAVELLESS, the Virtual Workshop Solution for Pharma
Valid Insight’s virtual workshops can provide a cost-and-time effective solution, eliminating the challenges above, without any IT and technology concerns.
-
New opportunities in emerging markets
aggressive cost containment measures).
-
Havas Lynx Launches Specialist Clinical Trial Recruitment Agency, Havas Lynx Faze
cost of finding patients.
-
Stephen Fry voices new Aardman animation on the shocking state of mental health worldwide
Suicide is the second leading cause of death among 15-29 year-olds worldwide, and mental ill health currently costs the world 2.5 trillion dollars per year.
-
Planning a pharma exhibition stand? You must read this!
Establishing what you need to achieve ROI. To do this, set out how much the exhibition is costing you to attend (including the cost of your exhibition stand) and attach a
More from PMHub
Approximately 3 fully matching, plus 340 partially matching documents found.
Featured jobs
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Director – UK Office
-
Excellent salary and benefits
Subscribe to our email news alerts
- Finch Therapeutics bags $53m for microbiome therapies
- MSD taps Austria’s Themis to bolster vaccine pipeline
- Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate
- GSK preps filings for BCMA-targeting multiple myeloma drug
- Behaviour change – is there something missing?
- NICE’s long-serving chief exec Sir Andrew Dillon to step down
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
